ArticlePakistan journal of medical sciences2026
The efficacy of Qingjin Huazhuo Decoction combined with acupuncture therapy on pulmonary function and quality of life in patients with acute exacerbation of chronic obstructive pulmonary disease.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the efficacy of Qingjin Huazhuo Decoction combined with acupuncture in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methodology: A retrospective analysis was conducted on 80 AECOPD patients admitted between October 2023 and February 2025. Patients were divided into a control group (n=40, treated with standard Western medicine) and a study group (n=40, treated with standard therapy plus Qingjin Huazhuo Decoction and acupuncture). Pulmonary function, clinical symptoms, exercise capacity, inflammatory markers, blood gas parameters, and adverse events were compared before and after treatment. Results: After treatment, both groups showed improvements in pulmonary function indicators (FEV1, FVC, PEF, FEV1/FVC), with the study group showing significantly greater gains (P<0.05). The study group also had greater improvements in mMRC and CAT scores, and longer 6-minute walk distance. Serum IL-6 and CRP levels declined significantly in both groups, with larger reductions observed in the study group (P<0.05). Post-treatment PaCO Conclusion: In this retrospective analysis, Qingjin Huazhuo Decoction combined with acupuncture therapy was associated with improved pulmonary function, exercise capacity, symptom/health status, inflammatory markers, and blood gas parameters in hospitalized patients with AECOPD, with comparable safety to conventional therapy. These findings are hypothesis-generating and should be confirmed in prospective randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.